CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110

BACKGROUND: In the search for novel antibody-drug conjugates (ADCs) with therapeutic potential, it is imperative to identify novel targets to direct the antibody moiety. CD13 seems an attractive ADC target as it shows a differential pattern of expression in a variety of tumors and cell lines and it...

Descripción completa

Detalles Bibliográficos
Autores principales: Domínguez, Juan Manuel, Pérez-Chacón, Gema, Guillén, María José, Muñoz-Alonso, María José, Somovilla-Crespo, Beatriz, Cibrián, Danay, Acosta-Iborra, Bárbara, Adrados, Magdalena, Muñoz-Calleja, Cecilia, Cuevas, Carmen, Sánchez-Madrid, Francisco, Avilés, Pablo, Zapata, Juan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140356/
https://www.ncbi.nlm.nih.gov/pubmed/32264921
http://dx.doi.org/10.1186/s13045-020-00865-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140356/
https://www.ncbi.nlm.nih.gov/pubmed/32264921
http://dx.doi.org/10.1186/s13045-020-00865-7

Ejemplares similares